A New Pre-print Answers Some Questions About Age-related Immunopathologies Associated with empty LNPs
Jessica Rose A new preprint was uploaded on November 7, 2022 entitled: “Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals” by a ‘non-conflicted group of researchers’ from… Acuitas? Wait, what? … Acuitas is the Canadian Biotech company that makes the proprietary Pfizer/BioNTech LNPs. … the paper reveals […]
Cumulative Inactivated Vaccine Exposure and Allergy Development Among Children: A Birth Cohort from Japan
Kiwako Yamamoto-Hanada et al. Adjuvants used in inactivated vaccines often upregulate type 2 immunity, which is dominant in allergic diseases. We hypothesised that cumulative adjuvant exposure in infancy may influence the development of allergies later in life by changing the balance of type 1/type 2 immunity. We examined the relationship between immunisation with different vaccine […]
Vaccines and the Brain
VaccinePapers.org Powerful scientific evidence shows 2 ways vaccines cause brain damage: Aluminum Adjuvant Toxicity Immune System Activitation
How Can Vaccines Cause Damage?
No vaccine is perfectly safe. An adverse event can be said to be caused by a vaccine (i.e., a true reaction) if it is associated with a specific laboratory finding and a specific clinical syndrome or both. Alternatively, a clinical or epidemiological study is needed to find out whether the rate of a given syndrome […]
What You Don’t Know Could Hurt You: Novavax’s ‘Loud-and-Clear’ Nanoparticle Adjuvant
CHD Team The U.S. Food and Drug Administration (FDA) last week granted Novavax Emergency Use Authorization (EUA) for its COVID-19 vaccine, for adults age 18 and up. … The media’s obliging sales pitch is that the Novavax injection is a “game changer” in comparison to the mRNA and adenovirus-vectored gene therapy shots, and should be […]
FDA Authorizes ‘Traditional’ Novavax COVID Vaccine, But Critics Question Safety Claims
Julie Comber The Novavax vaccine relies on a protein-based technology used for decades, leading some media outlets to portray it as a “traditional” vaccine compared with other COVID-19 vaccines that use newer technologies. … Novavax “may appeal to the sliver of the population allergic to components of the messenger RNA vaccines developed by Pfizer-BioNTech and Moderna, or […]
